141 related articles for article (PubMed ID: 21459782)
1. Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor.
Vaziri ND; Gollapudi P; Han S; Farahmand G; Yuan J; Rahimi A; Moradi H
Nephrol Dial Transplant; 2011 Oct; 26(10):3118-23. PubMed ID: 21459782
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome.
Liang K; Vaziri ND
Kidney Int; 1999 Aug; 56(2):621-6. PubMed ID: 10432401
[TBL] [Abstract][Full Text] [Related]
3. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND
Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy.
Kim S; Kim CH; Vaziri ND
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E813-7. PubMed ID: 15585592
[TBL] [Abstract][Full Text] [Related]
5. Regulation of SR-BI protein levels by phosphorylation of its associated protein, PDZK1.
Nakamura T; Shibata N; Nishimoto-Shibata T; Feng D; Ikemoto M; Motojima K; Iso-O N; Tsukamoto K; Tsujimoto M; Arai H
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13404-9. PubMed ID: 16174736
[TBL] [Abstract][Full Text] [Related]
6. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
Vaziri ND; Liang KH
Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits.
Zhao SP; Wu ZH; Hong SC; Ye HJ; Wu J
Clin Chim Acta; 2006 Mar; 365(1-2):119-24. PubMed ID: 16185675
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II down-regulates the SR-BI HDL receptor in proximal tubular cells.
Wolf G; Wenzel U; Jablonski K; Brundert M; Rinninger F
Nephrol Dial Transplant; 2005 Jun; 20(6):1222-7. PubMed ID: 15894808
[TBL] [Abstract][Full Text] [Related]
9. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
Hong SC; Zhao SP; Wu ZH
Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
[TBL] [Abstract][Full Text] [Related]
10. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
Vaziri ND; Liang K
Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
[TBL] [Abstract][Full Text] [Related]
11. Signaling by the high-affinity HDL receptor scavenger receptor B type I.
Saddar S; Mineo C; Shaul PW
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):144-50. PubMed ID: 20089950
[TBL] [Abstract][Full Text] [Related]
12. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis.
Trigatti BL; Krieger M; Rigotti A
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1732-8. PubMed ID: 12920050
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.
Kozarsky KF; Donahee MH; Rigotti A; Iqbal SN; Edelman ER; Krieger M
Nature; 1997 May; 387(6631):414-7. PubMed ID: 9163428
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome.
Vaziri ND; Liang K
Kidney Int; 2002 May; 61(5):1769-75. PubMed ID: 11967026
[TBL] [Abstract][Full Text] [Related]
15. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolism.
Leiva A; Verdejo H; Benítez ML; Martínez A; Busso D; Rigotti A
Atherosclerosis; 2011 Aug; 217(2):299-307. PubMed ID: 21741044
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of CLA-1 and human PDZK1 in murine liver modulates HDL cholesterol metabolism.
Komori H; Arai H; Kashima T; Huby T; Kita T; Ueda Y
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1298-303. PubMed ID: 18403724
[TBL] [Abstract][Full Text] [Related]
18. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
Vaziri ND
Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.
Vaziri ND; Kim CH; Phan D; Kim S; Liang K
Kidney Int; 2004 Jul; 66(1):262-7. PubMed ID: 15200432
[TBL] [Abstract][Full Text] [Related]
20. Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome.
Vaziri ND; Liang K; Parks JS
Am J Physiol Renal Physiol; 2001 May; 280(5):F823-8. PubMed ID: 11292624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
